WallStreetZenWallStreetZen

NASDAQ: BVS
Bioventus Inc Stock Ownership - Who owns Bioventus?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bioventus Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John A. BartholdsonDirector2024-08-1925,500$8.55
$217.97kBuy
John A. BartholdsonDirector2024-08-1680,000$8.55
$683.76kBuy
Mark Leonard SingletonSVP CFO2024-06-219,219$5.57
$51.35kSell
Katrina J. ChurchSVP Chief Compliance Officer2024-06-212,559$5.57
$14.25kSell
Anthony DadamioSVP General Counsel2024-06-215,904$5.57
$32.89kSell
Mark Leonard SingletonSVP CFO2024-06-1713,753$5.84
$80.32kSell
Anthony DadamioSVP General Counsel2024-06-1711,308$5.84
$66.04kSell
Katrina J. ChurchSVP Chief Compliance Officer2024-06-178,759$5.84
$51.15kSell
Katrina J. ChurchSVP Chief Compliance Officer2024-04-111,325$4.75
$6.29kSell
Mark Leonard SingletonSVP CFO2024-04-114,000$4.75
$19.00kSell

1 of 2

BVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BVS insiders and whales buy or sell their stock.

BVS Shareholders

What type of owners hold Bioventus Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Smith Nephew PLC20.37%16,534,814$188.83MInsider
Juniper Investment Company LLC16.23%13,168,697$150.39MInsider
Martin P. Sutter16.12%13,080,072$149.37MInsider
Ew Healthcare Partners Acquisition Fund LP16.05%13,021,324$148.70MInsider
Essex Woodlands Management Inc16.05%13,021,324$148.70MInstitution
John A. Bartholdson8.61%6,984,909$79.77MInsider
Juniper Investment Company LLC8.55%6,939,357$79.25MInstitution
Nantahala Capital Management LLC5.36%4,350,870$49.69MInstitution
Spindletop Healthcare Capital LP4.81%3,906,395$44.61MInsider
Ampcf Holdings LLC4.01%3,255,332$37.18MInsider

1 of 3

BVS vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BVS35.99%64.01%Net Buying
FNA21.49%78.51%Net SellingNet Selling
AVNS92.96%3.14%Net Buying
CTKB58.20%21.81%Net SellingNet Selling
CBLL0.00%27.08%Net BuyingNet Buying
View Top Medical Device Stocks

Bioventus Stock Ownership FAQ

Who owns Bioventus?

Bioventus (NASDAQ: BVS) is owned by 55.38% institutional shareholders, 98.49% Bioventus insiders, and 0.00% retail investors. Smith Nephew PLC is the largest individual Bioventus shareholder, owning 16.53M shares representing 20.37% of the company. Smith Nephew PLC's Bioventus shares are currently valued at $191.47M.

If you're new to stock investing, here's how to buy Bioventus stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.